Opioid use disorder incidence and treatment among incarcerated pregnant women in the United States: results from a national surveillance study.
Carolyn SufrinLauren SutherlandLauren BealMishka TerplanCarl A LatkinJennifer G ClarkePublished in: Addiction (Abingdon, England) (2020)
In this sample of US prisons and jails, one-third required pregnant women with opioid use disorder to go through withdrawal, contrary to medical guidelines. More women were prescribed methadone than buprenorphine, despite the fewer regulatory barriers on prescribing buprenorphine. Most sites stopped medication for opioid use disorder postpartum, signaling prioritization of the fetus, not the mother. Pregnant incarcerated women with opioid use disorder in the United States frequently appear to be denied essential medications and receive substandard medical care.